[Postoperative immunological capacity after coronary artery bypass grafting in a patient with chronic hemodialysis: comparison with data from patients without chronic hemodialysis].
Recently, coronary artery bypass grafting (CABG) has been performed safely in patients maintained on hemodialysis. However, the postoperative immunological capacity of patients undergoing CABG during chronic hemodialysis has not been fully investigated. Recently we performed CABG in a patient undergoing chronic hemodialysis and measured the immunological parameters. The WBC count, the populations of lymphocytes, OKT 4-positive cells, and OKT 8-positive cells, and NK activity were determined, and the lymphocyte stimulation test (using PHA) was performed before and after cardiopulmonary bypass, then, 1, 3, and 6 days after CABG. We compared these data with those from 17 patients without chronic hemodialysis. The immunological capacity after CABG in the patient with chronic hemodialysis was similar to that of patients without chronic hemodialysis. We suggest that CABG in patients with chronic hemodialysis is a safe operation with regard to the immunological capacity.
Shirasawa
B
B
First Department of Surgery, Yamaguchi University School of Medicine, Ube, Japan.
Hamano
K
K
Ito
H
H
Gohra
H
H
Katoh
T
T
Fujimura
Y
Y
Tsuboi
H
H
Esato
K
K
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000150:complications / Q000276:immunology* / Q000601:surgery*; D016516:CD4-CD8 Ratio; D001026:Coronary Artery Bypass; D003602:Cytotoxicity, Immunologic; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000276:immunology*; D007694:Killer Cells, Natural / Q000276:immunology; D007958:Leukocyte Count; D008213:Lymphocyte Activation; D008875:Middle Aged; D006435:Renal Dialysis